Editing
Management of Localized Prostate Cancer
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Answers == # What is the risk of cancer-specific death and the risk of metastasis at 10-years in males on watchful waiting for prostate cancer? ## Risk of death from prostate cancer: 15% ## Risk of metastasis: 20% # Which patients should be considered for watchful waiting as management for their prostate cancer? ## Preferred for all males without high-risk disease who have < 5-year life expectancy ## Option for those without high-risk disease and a life expectancy < 10 years # List the indications for intervention on active surveillance for prostate cancer ## Progression in cancer grade ## Increased cancer volume on repeat biopsy ## Rapidly rising PSA ## Patient anxiety # What are the contraindications to radical radiotherapy for prostate cancer? #* '''ST-LIAR''' ## Size >60g for brachytherapy ## Prior TURP for brachytherapy ## LUTS ## IBD ## Ataxia telangiectaisia ## Radiation # What are advantages/disadvantages of the perineal vs. retropubic prostatectomy? #* Advantages: reduced blood loss, shorter operating time #* Disadvantages: inability to do lymph node dissection, potential for rectal injury # What are the definitions of biochemical failure following radical radiotherapy for localized prostate cancer? #* ASTRO: 3 consecutive PSA increases measured 6 months apart, and back-dates the time of cancer progression to halfway between the PSA nadir and the first rising PSA level #* Phoenix definition: rise of 2 ng/mL or more above the nadir; failure is not backdated # What is the definition of a PSA bounce? Is it more common after EBRT or brachytherapy? #* Definition: a rise in PSA of 0.1-0.5ng/mL above nadir followed by a decline #* More common after brachytherapy # What is the optimal timing to perform a prostate biopsy to rule out recurrence after radiation treatment? #* After 30-36 months # What is the toxicity profile of radiotherapy for prostate cancer? How does the toxicity differ for EBRT and brachytherapy? #* GI toxicity (urgency, frequency, bleeding), GU toxicity (frequency, hematuria), secondary malignancies, sexual dysfuncion #* GU toxicity more likely with brachy, GI and ED toxicity more likely with EBRT
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information